Home › Funds › Avoro Capital Advisors LLC › UTHR
Avoro Capital Advisors LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Avoro Capital Advisors LLC reported holding 2,755,555 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$1.49B, representing 15.45% of its reported portfolio and ranking #1 among its reported holdings. Avoro Capital Advisors LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's UTHR position evolved
Avoro Capital Advisors LLC first disclosed a stake in UTHR in Q3 2023 at 2,852,500 shares (US$644.3M). The position peaked in Q2 2026 at 2,777,777 shares, worth US$1.51B. Across 13 filings, Avoro Capital Advisors LLC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,755,555 shares valued at US$1.49B — a reduction of -22,222 shares quarter over quarter.. Notable position changes include a 92% trim in Q3 2025 (shares rose 16% over the following quarter), a 1203% increase in Q4 2025 (shares rose 22% over the following quarter), a 631% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.85M | $644.29M | New |
| Q4 2023 | 2.86M | $628.64M | Hold |
| Q1 2024 | 2.86M | $656.74M | Hold |
| Q2 2024 | 2.86M | $910.70M | Hold |
| Q3 2024 | 2.86M | $1.02B | Hold |
| Q4 2024 | 2.76M | $973.94M | Reduce |
| Q1 2025 | 2.67M | $824.62M | Reduce |
| Q2 2025 | 2.37M | $681.02M | Reduce |
| Q3 2025 | 200.00K | $4.44M | Reduce |
| Q4 2025 | 2.61M | $1.27B | Add |
| Q1 2026 | 380.00K | $10.30M | Reduce |
| Q2 2026 | 2.78M | $1.51B | Add |
| Q3 2026 | 2.76M | $1.49B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$247.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 324.73K sh · $175.97M · Q3 2026
- Deep Track Capital, LP 300.04K sh · $162.59M · Q3 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held UTHR?
Avoro Capital Advisors LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Avoro Capital Advisors LLC's current position in UTHR?
As of Q3 2026, Avoro Capital Advisors LLC holds 2.76M shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $1.49B, representing 15.45% of its reported portfolio and ranking #1.
Has Avoro Capital Advisors LLC been buying or selling UTHR?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in UTHR. The position peaked in Q2 2026 at 2.78M shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Renaissance Technologies, ASSETMARK, INC, DEERFIELD MANAGEMENT COMPANY, L.P., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.